An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Nausea|Vomiting|Breast Neoplasms
Interventions: DRUG: MK0869, aprepitant / Duration of Treatment: 3 days|DRUG: Comparator: ondansetron / Duration of Treatment: 3 days
Sponsor: Merck Sharp & Dohme LLC